Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis

BioMed Research International - United States
doi 10.1155/2019/1093815
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Size Matters: Dissecting Key Parameters for Panel-Based Tumor Mutational Burden (TMB) Analysis

International Journal of Cancer
Cancer ResearchOncology
2018English

Integrated Analysis of the Immunological and Genetic Status in and Across Cancer Types: Impact of Mutational Signatures Beyond Tumor Mutational Burden

OncoImmunology
OncologyAllergyImmunology
2018English

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-Cancer-Gene Panel

Journal of Cancer
Oncology
2018English

An Exon Signature to Estimate the Tumor Mutational Burden of Right-Sided Colon Cancer Patients

Journal of Cancer
Oncology
2020English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Malignant Solitary Fibrous Tumor of the Urinary Bladder: Clinical and Pathological Challenges of a Rare Tumor

Journal of Clinical Case Studies
2017English

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Searching for New Biomarkers of Bladder Cancer Based on Proteomic Analysis

Journal of Electrophoresis
2008English

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

JAMA network open
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy